MITOMYCIN-C AS AN ADJUVANT IN RESECTED GASTRIC-CANCER

被引：56

作者：

ALCOBENDAS, F

MILLA, A

ESTAPE, J

CURTO, J

PERA, C

机构：

[1] FAC MED BARCELONA,SERV COORDINAC ONCOL,C CASANOVA 143,BARCELONA 36,SPAIN

[2] HOSP LLOBREGAT,RESIDENCIA SANITARIA PRINCIPES ESPANA,SERV CIRUGIA A,BARCELONA,SPAIN

[3] HOSP CLIN & PROVINCIAL,CATEDRA PATOL & CLIN QUIRURG 3,BARCELONA,SPAIN

来源：

关键词：

D O I：

10.1097/00000658-198307000-00004

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：13 / 17

页数：5

共 11 条

[1] INTEGRATION OF CHEMOTHERAPY INTO COMBINED MODALITY TREATMENT OF SOLID TUMORS .3. GASTRIC CANCER
COMIS, RL
CARTER, SK
[J]. CANCER TREATMENT REVIEWS, 1974, 1 (03) : 221 - 238
[2] MITOMYCIN-C - REVIEW
CROOKE, ST
BRADNER, WT
[J]. CANCER TREATMENT REVIEWS, 1976, 3 (03) : 121 - 139
[3] ESTAPE J, 1981, PROGR PERSPECTIVES T, P44
[4] IMANAGA H, 1977, WORLD J SURG, V1, P213
[5] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
KAPLAN, EL
MEIER, P
[J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
[6] KIMURA T, 1975, CANCER CHEMOTHER JPN, V2, P391
[7] MACDONALD JS, 1982, CANCER PRINCIPLES PR, P588
[8] MILLA A, 1976, 3 REUN NAC QUIM ANT
[9] MOERTEL CG, 1981, ADJUVANT THERAPY CAN, V3, P559
[10] CONSERVATISM OF APPROXIMATION SIGMA (O - E)2/E IN LOGRANK TEST FOR SURVIVAL DATA OR TUMOR INCIDENCE DATA
PETO, R
PIKE, MC
[J]. BIOMETRICS, 1973, 29 (03) : 579 - 584